SNIBE(SZ:300832) Xin Lang Cai Jing·2026-01-14 07:12Group 1 - New Industry's stock price has dropped 1.27% to 58.96 CNY per share, with a trading volume of 425 million CNY and a turnover rate of 1.06%, resulting in a total market capitalization of 46.326 billion CNY [1] - The stock has experienced a continuous decline over three days, with a cumulative drop of 6.14% [1] - New Industry Biomedical Engineering Co., Ltd. specializes in the research, development, production, and sales of fully automated chemiluminescence immunoassay instruments and related reagents, with revenue composition of 69.62% from reagents, 30.21% from instruments, and 0.16% from other sources [1] Group 2 - Huazhang Fund has one fund heavily invested in New Industry, specifically the Huazhang CSI Medical Device Index Fund A (021469), which increased its holdings by 8,900 shares to a total of 15,300 shares, representing 3.33% of the fund's net value, making it the fifth largest holding [2] - The fund has incurred a floating loss of approximately 11,600 CNY today and a total floating loss of 59,100 CNY during the three-day decline [2] - The Huazhang CSI Medical Device Index Fund A (021469) was established on November 5, 2024, with a latest scale of 15.8869 million CNY, and has achieved a year-to-date return of 11.11% and a one-year return of 18.53% [2] Group 3 - The fund manager of Huazhang CSI Medical Device Index Fund A is Su Qingyun, who has a tenure of 9 years and 29 days, managing total assets of 4.628 billion CNY, with the best fund return during the tenure being 127.62% and the worst being -62.44% [3]